Advisory Committee for Women's Services (ACWS); Notice of Meeting, 13724-13725 [2021-04935]

Download as PDF 13724 Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; NCATS Conference Grants Special Emphasis Panel. Date: March 22, 2021. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 100, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Alumit Ishai, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, MD 20892, 301–827–5819, alumit.ishai@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: March 4, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–04890 Filed 3–9–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 17:22 Mar 09, 2021 Jkt 253001 Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NIH Support for Conferences and Scientific Meetings. Date: April 8, 2021. Time: 1:00 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, (301) 827–7085, zhihong.shan@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: March 4, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–04892 Filed 3–9–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Using Syndemics to Understand HLBS Disease in People with HIV. Date: April 16, 2021. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208– PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Z, Bethesda, MD 20892, (301) 827–7987, susan.sunnarborg@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: March 4, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–04889 Filed 3–9–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Advisory Committee for Women’s Services (ACWS); Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of a meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Advisory Committee for Women’s Services (ACWS) on March 31, 2021. The meeting will include discussions on assessing SAMHSA’s current strategies, including the mental health and substance use needs of the women and girls population. Additionally, the ACWS will be addressing priorities regarding the impact of COVID–19 on the behavioral health needs of women and children and directions around behavioral health services and access for women and children. The meeting is open to the public and will be held virtually only. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions should be forwarded to the contact person by March 23, 2021. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact person on or before March 23, 2021. Up to five minutes will be allotted for each presentation. The meeting may be accessed via telephone or web meeting. To obtain the call-in number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register on-line at https:// snacregister.samhsa.gov/ MeetingList.aspx, or communicate with the ACWS Designated Federal Officer, Ms. Valerie Kolick. E:\FR\FM\10MRN1.SGM 10MRN1 Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices Substantive meeting information and a roster of ACWS members may be obtained either by accessing the SAMHSA Committees’ web page at: https://www.samhsa.gov/about-us/ advisory-councils/meetings, or by contacting Ms. Kolick. Committee Name: Substance Abuse and Mental Health Services Administration Advisory Committee for Women’s Services (ACWS). Date/Time/Type: Wednesday, March 31, 2021, from: 1:00 p.m. to 4:30 p.m. EDT (OPEN). Place: SAMHSA, 5600 Fishers Lane, Rockville, MD 20857 (Virtual). Contact: Valerie Kolick, Designated Federal Officer, SAMHSA’s Advisory Committee for Women’s Services, 5600 Fishers Lane, Rockville, MD 20857, Telephone: (240) 276–1738, Email: Valerie.kolick@samhsa.hhs.gov. Dated: March 4, 2021, Carlos Castillo, Captain, Committee Management Officer, Substance Abuse and Mental Health Services Administration. [FR Doc. 2021–04935 Filed 3–9–21; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency Changes in Flood Hazard Determinations Federal Emergency Management Agency, Department of Homeland Security. ACTION: Notice. AGENCY: This notice lists communities where the addition or modification of Base Flood Elevations (BFEs), base flood depths, Special Flood Hazard Area (SFHA) boundaries or zone designations, or the regulatory floodway (hereinafter referred to as flood hazard determinations), as shown on the Flood Insurance Rate Maps (FIRMs), and where applicable, in the supporting Flood Insurance Study (FIS) reports, prepared by the Federal Emergency Management Agency (FEMA) for each community, is appropriate because of VerDate Sep<11>2014 17:22 Mar 09, 2021 Jkt 253001 These flood hazard determinations will be finalized on the dates listed in the table below and revise the FIRM panels and FIS report in effect prior to this determination for the listed communities. From the date of the second publication of notification of these changes in a newspaper of local circulation, any person has 90 days in which to request through the community that the Deputy Associate Administrator for Insurance and Mitigation reconsider the changes. The flood hazard determination information may be changed during the 90-day period. DATES: The affected communities are listed in the table below. Revised flood hazard information for each community is available for inspection at both the online location and the respective community map repository address listed in the table below. Additionally, the current effective FIRM and FIS report for each community are accessible online through the FEMA Map Service Center at https:// msc.fema.gov for comparison. Submit comments and/or appeals to the Chief Executive Officer of the community as listed in the table below. ADDRESSES: [Docket ID FEMA–2021–0002; Internal Agency Docket No. FEMA–B–2117] SUMMARY: new scientific or technical data. The FIRM, and where applicable, portions of the FIS report, have been revised to reflect these flood hazard determinations through issuance of a Letter of Map Revision (LOMR), in accordance with Federal Regulations. The LOMR will be used by insurance agents and others to calculate appropriate flood insurance premium rates for new buildings and the contents of those buildings. For rating purposes, the currently effective community number is shown in the table below and must be used for all new policies and renewals. Rick Sacbibit, Chief, Engineering Services Branch, Federal Insurance and Mitigation Administration, FEMA, 400 C Street SW, Washington, DC 20472, (202) 646–7659, or (email) patrick.sacbibit@fema.dhs.gov; or visit the FEMA Mapping and Insurance eXchange (FMIX) online at https:// www.floodmaps.fema.gov/fhm/fmx_ main.html. FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 13725 The specific flood hazard determinations are not described for each community in this notice. However, the online location and local community map repository address where the flood hazard determination information is available for inspection is provided. Any request for reconsideration of flood hazard determinations must be submitted to the Chief Executive Officer of the community as listed in the table below. The modifications are made pursuant to section 201 of the Flood Disaster Protection Act of 1973, 42 U.S.C. 4105, and are in accordance with the National Flood Insurance Act of 1968, 42 U.S.C. 4001 et seq., and with 44 CFR part 65. The FIRM and FIS report are the basis of the floodplain management measures that the community is required either to adopt or to show evidence of having in effect in order to qualify or remain qualified for participation in the National Flood Insurance Program (NFIP). These flood hazard determinations, together with the floodplain management criteria required by 44 CFR 60.3, are the minimum that are required. They should not be construed to mean that the community must change any existing ordinances that are more stringent in their floodplain management requirements. The community may at any time enact stricter requirements of its own or pursuant to policies established by other Federal, State, or regional entities. The flood hazard determinations are in accordance with 44 CFR 65.4. The affected communities are listed in the following table. Flood hazard determination information for each community is available for inspection at both the online location and the respective community map repository address listed in the table below. Additionally, the current effective FIRM and FIS report for each community are accessible online through the FEMA Map Service Center at https:// msc.fema.gov for comparison. SUPPLEMENTARY INFORMATION: (Catalog of Federal Domestic Assistance No. 97.022, ‘‘Flood Insurance.’’) Michael M. Grimm, Assistant Administrator for Risk Management, Department of Homeland Security, Federal Emergency Management Agency. E:\FR\FM\10MRN1.SGM 10MRN1

Agencies

[Federal Register Volume 86, Number 45 (Wednesday, March 10, 2021)]
[Notices]
[Pages 13724-13725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04935]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Advisory Committee for Women's Services (ACWS); Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Advisory Committee for Women's Services (ACWS) on March 31, 
2021.
    The meeting will include discussions on assessing SAMHSA's current 
strategies, including the mental health and substance use needs of the 
women and girls population. Additionally, the ACWS will be addressing 
priorities regarding the impact of COVID-19 on the behavioral health 
needs of women and children and directions around behavioral health 
services and access for women and children.
    The meeting is open to the public and will be held virtually only. 
Interested persons may present data, information, or views, orally or 
in writing, on issues pending before the committee. Written submissions 
should be forwarded to the contact person by March 23, 2021. Oral 
presentations from the public will be scheduled at the conclusion of 
the meeting. Individuals interested in making oral presentations are 
encouraged to notify the contact person on or before March 23, 2021. Up 
to five minutes will be allotted for each presentation.
    The meeting may be accessed via telephone or web meeting. To obtain 
the call-in number and access code, submit written or brief oral 
comments, or request special accommodations for persons with 
disabilities, please register on-line at https://snacregister.samhsa.gov/MeetingList.aspx, or communicate with the ACWS 
Designated Federal Officer, Ms. Valerie Kolick.

[[Page 13725]]

    Substantive meeting information and a roster of ACWS members may be 
obtained either by accessing the SAMHSA Committees' web page at: 
https://www.samhsa.gov/about-us/advisory-councils/meetings, or by 
contacting Ms. Kolick.
    Committee Name: Substance Abuse and Mental Health Services 
Administration Advisory Committee for Women's Services (ACWS).
    Date/Time/Type: Wednesday, March 31, 2021, from: 1:00 p.m. to 4:30 
p.m. EDT (OPEN).
    Place: SAMHSA, 5600 Fishers Lane, Rockville, MD 20857 (Virtual).
    Contact: Valerie Kolick, Designated Federal Officer, SAMHSA's 
Advisory Committee for Women's Services, 5600 Fishers Lane, Rockville, 
MD 20857, Telephone: (240) 276-1738, Email: 
[email protected].

    Dated: March 4, 2021,
Carlos Castillo,
Captain, Committee Management Officer, Substance Abuse and Mental 
Health Services Administration.
[FR Doc. 2021-04935 Filed 3-9-21; 8:45 am]
BILLING CODE 4162-20-P